7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

C53H59N9O11S — CID 155301722

IUPAC7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
SMILESCCc1c2c(nc3ccc(OC(O)N4CCN(S(=O)(=O)N5CCC(CCn6ccc7cc(-n8c(-c9cc(C(C)C)c(O)cc9O)n[nH]c8=O)ccc76)CC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC
InChIInChI=1S/C53H59N9O11S/c1-5-35-37-24-34(8-9-42(37)54-47-39(35)28-61-44(47)26-41-40(49(61)65)29-72-50(66)53(41,69)6-2)73-52(68)58-19-21-60(22-20-58)74(70,71)59-17-12-31(13-18-59)11-15-57-16-14-32-23-33(7-10-43(32)57)62-48(55-56-51(62)67)38-25-36(30(3)4)45(63)27-46(38)64/h7-10,14,16,23-27,30-31,52,63-64,68-69H,5-6,11-13,15,17-22,28-29H2,1-4H3,(H,56,67)
InChIKeyFJAVJRRALNCKLD-UHFFFAOYSA-N
MW1030.17 g/mol
LogP4.99
Rot. Bonds13

About 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione (PubChem CID 155301722) has the molecular formula C53H59N9O11S and a molecular weight of 1030.17 g/mol. Its IUPAC name is 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione.

Molecular Properties

Compound Name7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
PubChem CID155301722
Molecular FormulaC53H59N9O11S
Molecular Weight1030.17 g/mol
Exact Mass1029.41
IUPAC Name7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
SMILESCCc1c2c(nc3ccc(OC(O)N4CCN(S(=O)(=O)N5CCC(CCn6ccc7cc(-n8c(-c9cc(C(C)C)c(O)cc9O)n[nH]c8=O)ccc76)CC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC
InChIInChI=1S/C53H59N9O11S/c1-5-35-37-24-34(8-9-42(37)54-47-39(35)28-61-44(47)26-41-40(49(61)65)29-72-50(66)53(41,69)6-2)73-52(68)58-19-21-60(22-20-58)74(70,71)59-17-12-31(13-18-59)11-15-57-16-14-32-23-33(7-10-43(32)57)62-48(55-56-51(62)67)38-25-36(30(3)4)45(63)27-46(38)64/h7-10,14,16,23-27,30-31,52,63-64,68-69H,5-6,11-13,15,17-22,28-29H2,1-4H3,(H,56,67)
InChIKeyFJAVJRRALNCKLD-UHFFFAOYSA-N
XLogP4.99
TPSA250.81 Ų
H-Bond Donors5
H-Bond Acceptors17
Rotatable Bonds13
Heavy Atoms74
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001030.17
LogP ≤ 54.99
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione?
The IUPAC name of 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione (CID 155301722) is 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione.
What is the SMILES notation for 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione?
The canonical SMILES for 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione is CCc1c2c(nc3ccc(OC(O)N4CCN(S(=O)(=O)N5CCC(CCn6ccc7cc(-n8c(-c9cc(C(C)C)c(O)cc9O)n[nH]c8=O)ccc76)CC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC.
What is the InChIKey of 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione?
The InChIKey is FJAVJRRALNCKLD-UHFFFAOYSA-N. The full InChI is InChI=1S/C53H59N9O11S/c1-5-35-37-24-34(8-9-42(37)54-47-39(35)28-61-44(47)26-41-40(49(61)65)29-72-50(66)53(41,69)6-2)73-52(68)58-19-21-60(22-20-58)74(70,71)59-17-12-31(13-18-59)11-15-57-16-14-32-23-33(7-10-43(32)57)62-48(55-56-51(62)67)38-25-36(30(3)4)45(63)27-46(38)64/h7-10,14,16,23-27,30-31,52,63-64,68-69H,5-6,11-13,15,17-22,28-29H2,1-4H3,(H,56,67).
What are the key properties of 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione?
7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione has a molecular weight of 1030.17 g/mol, XLogP of 4.99, 13 rotatable bonds, 5 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidin-1-yl]sulfonylpiperazin-1-yl]-hydroxymethoxy]-10,19-diethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione is sourced from PubChem (CID 155301722), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).